US OptionsDetailed Quotes
RNAC240920C2500
- 0.04
- 0.000.00%
15min DelayClose Apr 3 15:14 ET
0.00High0.00Low
0.00Open0.04Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-85.68%PremiumSep 20, 2024Expiry Date15.24Intrinsic Value100Multiplier69DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma443.50Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cartesian Therapeutics Stock Discussion
Sign in to post a comment
$Cartesian Therapeutics(RNAC.US$ Press Release: Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
Dow Jones· just
Dow Jones· just
2
$Cartesian Therapeutics(RNAC.US$Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
1
7
$Cartesian Therapeutics(RNAC.US$ did no one notice springer just bought another 1.9million shares just today 👀, simply does not explain the price action point for this week at all. Eccentric !
$Cartesian Therapeutics(RNAC.US$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.
$Cartesian Therapeutics(RNAC.US$ there is 50 million shares buy-in (pending) from institutions, CRISPP recently shifted their interest on cell therapy as well, speak volume in the position that Cartesian is in.
$Cartesian Therapeutics(RNAC.US$ Cartesian plans to hold a special meeting of stockholders on March 27, 2024 to seek stockholder approval for the conversion of the Company’s Series A Non-Voting Convertible Preferred Stock into the Company’s common stock and a reverse stock split at a ratio in the range of 1 for 20 and 1 for 30.
$Cartesian Therapeutics(RNAC.US$ 10% Shareholder SPRINGER TIMOTHY A purchased 1.19 million shares of Common Stocks on Mar 14, 15, 2024 at an average price of $0.5618 for a total value of $666.22K.
3
$Cartesian Therapeutics(RNAC.US$ Cartesian Therapeutics Establishes New Corporate Headquarters And MRNA Cell Therapy Manufacturing Facility in Frederick, Maryland
$Cartesian Therapeutics(RNAC.US$ Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of MRNA Cell Therapies for Autoimmunity![]()
$Cartesian Therapeutics(RNAC.US$ let’s gamble here
No comment yet
andy(三叔） : $Chicken Soup for the Soul Entertainment (CSSE.US)$ $Chicken Soup For The Soul Entmt Inc 9.50% Notes Due 2025 Usd25 (CSSEN.US)$ $Chicken Soup for the Soul Entertainment Inc (CSSEP.US)$
TrytosaveabitOP andy(三叔）: It’s a bankruptcy play from Redbox filing for protection!